Deletion of PPARγ in Alveolar Macrophages Is Associated with a Th-1 Pulmonary Inflammatory Response
- 1 May 2009
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 182 (9), 5816-5822
- https://doi.org/10.4049/jimmunol.0803504
Abstract
Peroxisome proliferator-activated receptor gamma (PPARgamma) is constitutively expressed at high levels in healthy alveolar macrophages, in contrast to other tissue macrophages and blood monocytes. PPARgamma ligands have been shown to down-regulate IFN-gamma-stimulated inducible NO synthase (iNOS) in macrophages. Because NO is an important inflammatory mediator in the lung, we hypothesized that deletion of alveolar macrophage PPARgamma in vivo would result in up-regulation of iNOS and other inflammatory mediators. The loss of PPARgamma in macrophages was achieved by crossing floxed (+/+) PPARgamma mice and a transgenic mouse containing the CRE recombinase gene under the control of the murine M lysozyme promoter (PPARgammaKO). Alveolar macrophages were harvested by bronchoalveolar lavage (BAL). Lymphocytes (CD8:CD4 ratio = 2.8) were increased in BAL of PPARgammaKO vs wild-type C57BL6; p < or = 0.0001. Both iNOS and IFN-gamma expression were significantly elevated (p < or = 0.05) in BAL cells. Th-1 associated cytokines including IL-12 (p40), MIP-1alpha (CCL3), and IFN inducible protein-10 (IP-10, CXCL10) were also elevated. IL-4 and IL-17A were not detected. To test whether these alterations were due to the lack of PPARgamma, PPARgamma KO mice were intratracheally inoculated with a PPARgamma lentivirus construct. PPARgamma transduction resulted in significantly decreased iNOS and IFN-gamma mRNA expression, as well as reduced BAL lymphocytes. These results suggest that lack of PPARgamma in alveolar macrophages disrupts lung homeostasis and results in a Th1-like inflammatory response.Keywords
This publication has 44 references indexed in Scilit:
- PPARs and molecular mechanisms of transrepressionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- An inverse relationship between peroxisome proliferator–activated receptor γ and allergic airway inflammation in an allergen challenge modelAnnals of Allergy, Asthma & Immunology, 2005
- Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factorJournal of Leukocyte Biology, 2005
- Pioglitazone, a peroxisome proliferator-activated receptor ? activator, ameliorates experimental autoimmune myocarditis by modulating Th1/Th2 balanceJournal of Molecular and Cellular Cardiology, 2005
- Interferon-γ: an overview of signals, mechanisms and functionsJournal of Leukocyte Biology, 2003
- Peroxisome Proliferator–activated Receptors α and γ Down-regulate Allergic Inflammation and Eosinophil ActivationThe Journal of Experimental Medicine, 2003
- PPAR‐α and ‐γ but not ‐δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF‐κB‐independent effectBritish Journal of Pharmacology, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Interferon-γ-induced Regulation of Peroxisome Proliferator-activated Receptor γ and STATs in AdipocytesJournal of Biological Chemistry, 2001
- Interferon gamma upregulates its own gene expression in mouse peritoneal macrophages.The Journal of Experimental Medicine, 1994